Opinion|Videos|June 28, 2024

Biologics Utilization Impacting US Health Care Spending

Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, and Chad Cannon, PharmD, BCCCP, open a panel discussion highlighting specialty biologics and navigating challenges for biosimilar uptake.

Video content above is prompted by the following:

  • How significant is the impact of specialty medications, particularly biologics, on current US health care spending?
  • What have been the major challenges and successes in reducing health care costs through the use of biosimilars?
    • Briefly, what is hindering biosimilar uptake?
    • Where have biosimilars been successful?
  • What are some strategies for successful biosimilar adoption?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo